Tuesday, May 17, 2022 1:05:32 PM
I think Venkat bought this ticker because he thinks this new acne topical treatment has the potential to be very sucessful. If I remember correctly, the Vyome website states that Phase 2 was successfully completed in June of 2020 (almost 2 years ago). I fail to find any evidence that Phase 3 testing has begun. (Sucessful Phase 3 required before FDA approval).
If anyone contacts Venkat or their CFO (Craig Tooman?), the best question is to ask them is the status of the Phase 3 trial. Successful Phase 3 trial is the lynchpin of this ticker.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM